X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesstimes.com.sg/companies-markets/pfizer-end-licence-deal-syros-blood-disorder-therapies
https://www.ema.europa.eu/en/documents/overview/oxbryta-epar-medicine-overview_en.pdf
https://www.globenewswire.com/news-release/2022/09/08/2512447/37049/en/GBT-and-Sickle-Cell-Disease-Association-of-America-to-Host-11th-Annual-Sickle-Cell-Disease-Therapeutics-Conference.html
https://www.fiercepharma.com/pharma/johnson-johnson-lost-pfizer-global-blood-therapeutics-bidding-war-bloomberg
https://www.fiercepharma.com/pharma/how-pfizer-became-interested-global-blood-and-beat-deal-talk-firstcomer-54b-acquisition
https://www.biopharmadive.com/news/Eli-lilly-indiana-abortion-law-new-jobs/629109/
https://www.fiercepharma.com/pharma/pfizer-riding-high-covid-windfall-eyes-5b-play-global-blood-therapeutics-wsj
https://ir.gbt.com/news-releases/news-release-details/gbt-announces-new-employment-inducement-grants-58
https://www.globenewswire.com/news-release/2022/08/03/2491766/37049/en/GBT-Announces-Participation-at-the-Wedbush-PacGrow-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2022/07/29/2488710/37049/en/GBT-to-Announce-Second-Quarter-2022-Financial-Results-on-Monday-August-8-2022.html
Market Place
Share 
